Male and female drug prescription patterns and adverse drug reactions in chronic kidney disease
Solène M. Laville(Centre Hospitalier Universitaire Amiens-Picardie), H Sekhri(Laboratoire de recherche en cardiovasculaire, métabolisme, diabétologie et nutrition), Denis Fouque(Université Claude Bernard Lyon 1), Bruno Moulin(Université de Strasbourg), Thierry Lobbedez, Thierry Hannedouche, Benoı̂t Vendrely, C Delclaux(Inserm), Marie Metzger, Arielle S. Keller(University of Connecticut), Sophie Liabeuf(Centre Hospitalier Universitaire Amiens-Picardie), Christian Jacquelinet(Université Paris-Sud), Dorothée Cannet, Roberto Pecoits‐Filho(Pontifícia Universidade Católica do Paraná), Philippe Lang(Centre Hospitalier Universitaire de Nantes), Oriane Lambert(Inserm), Benjamin Deroure, Bénédicte Stengel(Inserm), Ziad A. Massy(Inserm), Xavier Belenfant(Centre Hospitalier Intercommunal André Grégoire Montreuil), Adeline Lacraz(Centre Hospitalier Universitaire de Bordeaux), Isabelle Landru(Inserm), Pascal Morel, Luc Frimat(Centre Hospitalier Régional et Universitaire de Nancy), Aghilès Hamroun(Université de Lille), Marie Essig, Natália Alencar de Pinho(Inserm), Agathe Mouheb(Centre Hospitalier Universitaire Amiens-Picardie), Christophe Pascal, Maurice Laville(Université Claude Bernard Lyon 1), Éric Thervet(Délégation Paris 5), Céline Lange, C Vela(Inserm), Michel Delahousse, Natalia Alencar de Pinho(Inserm), Pablo Ureña(Hôpital Necker-Enfants Malades), A Klein(Université de Bordeaux), J P Bourdenx, Yves-Édouard Herpe, Joost Schantsra(Inserm), Christian Combe(Université de Bordeaux)
Cited by 3
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
|Kidney International|2005|927